By Devika Patel
Knoxville, Tenn., Sept. 30 - Helix BioPharma Corp. announced it will raise C$11.42 million in a private placement of units.
The company will sell 6.8 million units of one common share and one half-share warrant at C$1.68 apiece. Each whole warrant will be exercisable at C$2.36 for three years.
Settlement is expected within 10 days.
Helix BioPharma is a biopharmaceutical company developing products for the treatment of cancer and pre-cancerous conditions.
| Issuer: | Helix BioPharma Corp.
|
| Issue: | Units of one common share and one half-share warrant
|
| Amount: | C$11,424,000
|
| Units: | 6.8 million
|
| Price: | C$1.68
|
| Warrants: | One half-share warrant per unit
|
| Warrant expiration: | Three years
|
| Warrant strike price: | C$2.36
|
| Pricing date: | Sept. 30
|
| Stock symbol: | Toronto: HBP
|
| Stock price: | C$1.63 at close Sept. 29
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
